Literature DB >> 21543568

Point: Should all stools be screened for Shiga toxin-producing Escherichia coli?

Mario J Marcon1.   

Abstract

In October 2009, the Centers for Disease Control and Prevention recommended that clinical laboratories test all stools submitted for the detection of enteric bacterial pathogens for the presence of Shiga toxin-producing Escherichia coli (STEC). In order to do this, it is recommended that all stools be cultured for Escherichia coli O157:H7 on selective medium as well as that testing for the presence of Shiga toxin be done by immunoassay to detect non-O157 STEC (3). There are a variety of products that are FDA approved for detection of Shiga toxin. Further, it is recommended that Shiga toxin detection be done by testing overnight enrichment broth cultures of stools rather than directly examining stools for this toxin. This recommendation was made approximately 18 months ago. We have asked Mario Marcon of Nationwide's Children Hospital in Columbus, OH, to explain the rationale for his decision to follow this recommendation, while we have asked Deanna Kiska and Scott Riddell of Upstate University Hospital in Syracuse, NY, why these guidelines have not been adopted by their laboratory.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543568      PMCID: PMC3147825          DOI: 10.1128/JCM.00817-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

Review 1.  Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?

Authors:  G Z Panos; G I Betsi; M E Falagas
Journal:  Aliment Pharmacol Ther       Date:  2006-09-01       Impact factor: 8.171

2.  Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.

Authors:  John T Brooks; Evangeline G Sowers; Joy G Wells; Katherine D Greene; Patricia M Griffin; Robert M Hoekstra; Nancy A Strockbine
Journal:  J Infect Dis       Date:  2005-09-14       Impact factor: 5.226

3.  Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli.

Authors:  K S Kehl; P Havens; C E Behnke; D W Acheson
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

4.  Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.

Authors:  Julie A Ake; Srdjan Jelacic; Marcia A Ciol; Sandra L Watkins; Karen F Murray; Dennis L Christie; Eileen J Klein; Phillip I Tarr
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

Review 5.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

6.  Continuous surveillance of Shiga toxin-producing Escherichia coli infections by pulsed-field gel electrophoresis shows that most infections are sporadic.

Authors:  Eva Møller Nielsen; Flemming Scheutz; Mia Torpdahl
Journal:  Foodborne Pathog Dis       Date:  2006       Impact factor: 3.171

7.  The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.

Authors:  Kristine E Johnson; Cheleste M Thorpe; Cynthia L Sears
Journal:  Clin Infect Dis       Date:  2006-11-09       Impact factor: 9.079

8.  Importance of culture confirmation of shiga toxin-producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis--New York and North Carolina, 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-09-29       Impact factor: 17.586

9.  Laboratory-confirmed non-O157 Shiga toxin-producing Escherichia coli--Connecticut, 2000-2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-01-19       Impact factor: 17.586

Review 10.  Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections.

Authors:  J C Paton; A W Paton
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more
  5 in total

1.  Four-year experience with simultaneous culture and Shiga toxin testing for detection of Shiga toxin-producing Escherichia coli in stool samples.

Authors:  Jennifer S Woo; Elizabeth L Palavecino
Journal:  J Clin Microbiol       Date:  2012-12-19       Impact factor: 5.948

2.  Clinical Evaluation and Cost Analysis of Great Basin Shiga Toxin Direct Molecular Assay for Detection of Shiga Toxin-Producing Escherichia coli in Diarrheal Stool Specimens.

Authors:  Matthew L Faron; Nathan A Ledeboer; Jessica Connolly; Paul A Granato; Brenda R Alkins; Jennifer Dien Bard; Judy A Daly; Stephen Young; Blake W Buchan
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

3.  Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010.

Authors:  Glenn Buvens; Yves De Gheldre; Anne Dediste; Anne-Isabelle de Moreau; Georges Mascart; Anne Simon; Daniël Allemeersch; Flemming Scheutz; Sabine Lauwers; Denis Piérard
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

4.  Clinical evaluation of a real-time PCR assay for identification of Salmonella, Shigella, Campylobacter (Campylobacter jejuni and C. coli), and shiga toxin-producing Escherichia coli isolates in stool specimens.

Authors:  Blake W Buchan; Wendy J Olson; Michael Pezewski; Mario J Marcon; Thomas Novicki; Timothy S Uphoff; Lakshmi Chandramohan; Paula Revell; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

Review 5.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.